Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 25.50
-0.05 (-0.20%)
At close: Mar 9, 2026
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 589.56 million as of March 9, 2026. Its market cap has decreased by -7.61% in one year.
Market Cap
589.56M
Enterprise Value
548.20M
Revenue
90.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.50
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 589.56M, an increase of 943.42%. That is a compound annual growth rate of 17.34%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 483.21M |
| Bioceltix | 382.14M |
| BIOTON | 355.48M |
| Synthaverse | 254.77M |
| Molecure | 147.93M |
| Mabion | 130.11M |
| Poltreg | 115.19M |
| NanoGroup | 82.89M |